Skip to main content

Table 3 Surgical procedure and pathological findings

From: A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma

 

n

%

Surgery

  

  Lower anterior resection

20

52.6%

  Abdominal perineal resection

15

39.5%

  Hartmann

3

7.9%

Lymphatic or vascular invasion

  

  Yes

34

89.5%

  No

4

10.5%

Neural invasion

  

  Yes

30

78.9%

  No

8

21.1%

Margin

  

  Negative

35

92.1%

  Positive

3

7.9%

ypT

  

  T0

10

26.3%

  T1

0

0.0%

  T2

7

18.4%

  T3

17

44.7%

  T4

4

10.5%

ypN

  

  N0

22

57.9%

  N1

12

31.6%

  N2

4

10.5%

TRG

  

  4

6

15.8%

  3

17

44.7%

  2

11

28.9%

  1

4

10.5%

Total

38

100.0%